Da Neoclarityn oral opløsning indeholder samme koncentration desloratadin, var et bioækvivalensstudie ikke nødvendigt, og det forventes at være ækvivalent med syrupen og tabletten.
As Neoclarityn oral solution contains the same concentration of desloratadine, no bioequivalence study was required and it is expected to be equivalent to the syrup and tablet.